Vanguard Group Inc Cytosorbents Corp Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,949,551 shares of CTSO stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,949,551
Previous 1,949,551
-0.0%
Holding current value
$1.68 Million
Previous $2.16 Million
14.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$2.73 Million0.27% of portfolio
-
Granahan Investment Management, LLC Waltham, MA3.04MShares$2.62 Million0.1% of portfolio
-
Skylands Capital, LLC2.88MShares$2.47 Million0.4% of portfolio
-
Neuberger Berman Group LLC New York, NY1.91MShares$1.64 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.37MShares$1.18 Million0.29% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...